2007

  1. Probiotics in CD for postop recurrence

  2. Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease

  3. Mesalazine high/low dose in UC

  4. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease

  5. Stressful Life Events as a Risk Factor for Inflammatory Bowel Disease Onset (case-controls)

  6. Sequence variants in the autophagy gene *IRGM* and multiple other replicating loci contribute to Crohn’s disease susceptibility

  7. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

  8. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

  9. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn’s disease in Japanese patients

  10. The risk of developing Crohn’s disease after an appendectomy: a population‐based cohort study in Sweden and Denmark